This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Vigneswaran N, Williams MD. Epidemiologic trends in head and neck cancer and aids in diagnosis. Oral Maxillofac. Surg. Clin. North Am. 2014; 26: 123–141.VigneswaranNWilliamsMDEpidemiologic trends in head and neck cancer and aids in diagnosisOral Maxillofac. Surg. Clin. North Am.20142612314110.1016/j.coms.2014.01.001404023624794262Search in Google Scholar
Heroiu Cataloiu AD, Danciu CE, Popescu CR. Multiple cancers of the head and neck. Maedica. 2013; 8: 80–85.Heroiu CataloiuADDanciuCEPopescuCRMultiple cancers of the head and neckMaedica.201388085Search in Google Scholar
Douglas CM, Ingarfield K, McMahon AD, Savage SA, Conway DI, MacKenzie K. Presenting symptoms and long-term survival in head and neck cancer. Clin. Otolaryngol. 2018; 43: 795–804.DouglasCMIngarfieldKMcMahonADSavageSAConwayDIMacKenzieKPresenting symptoms and long-term survival in head and neck cancerClin. Otolaryngol.20184379580410.1111/coa.1305329247495Search in Google Scholar
Huang SH, O’Sullivan B. Overview of the 8th edition TNM classification for head and neck cancer. Curr. Treat. Options Oncol. 2017; 18: 40.HuangSHO’SullivanBOverview of the 8th edition TNM classification for head and neck cancerCurr. Treat. Options Oncol.2017184010.1007/s11864-017-0484-y28555375Search in Google Scholar
Beynon RA, Lang S, Schimansky S, Penfold CM, Waylen A, Thomas SJ, Pawlita M, Waterboer T, Martin RM, May M, et al. Tobacco smoking and alcohol drinking at diagnosis of head and neck cancer and all-cause mortality: Results from head and neck 5000, a prospective observational cohort of people with head and neck cancer. Int. J. Cancer. 2018; 143: 1114–1127.BeynonRALangSSchimanskySPenfoldCMWaylenAThomasSJPawlitaMWaterboerTMartinRMMayMTobacco smoking and alcohol drinking at diagnosis of head and neck cancer and all-cause mortality: Results from head and neck 5000, a prospective observational cohort of people with head and neck cancerInt. J. Cancer.20181431114112710.1002/ijc.31416609936629607493Search in Google Scholar
Kobayashi K, Hisamatsu K, Suzui N, Hara A, Tomita H, Miyazaki T. A review of HPV-related head and neck cancer. J. Clin. Med. 2018; 7: 241.KobayashiKHisamatsuKSuzuiNHaraATomitaHMiyazakiTA review of HPV-related head and neck cancerJ. Clin. Med.2018724110.3390/jcm7090241616286830150513Search in Google Scholar
Báez A. Genetic and environmental factors in head and neck cancer genesis. J Environ Sci Health C Environ Carcinog. Ecotoxicol. Rev. 2008; 26: 174–200.BáezAGenetic and environmental factors in head and neck cancer genesisJ Environ Sci Health C Environ Carcinog. Ecotoxicol. Rev.20082617420010.1080/1059050080212943118569329Search in Google Scholar
Chuang SC, Jenab M, Heck JE, Bosetti C, Talamini R, Matsuo K, Castellsague X, Franceschi S, Herrero R, Winn DM, et al. Diet and the risk of head and neck cancer: A pooled analysis in the INHANCE consortium. Cancer Causes Control, 2012; 23: 69–88.ChuangSCJenabMHeckJEBosettiCTalaminiRMatsuoKCastellsagueXFranceschiSHerreroRWinnDMDiet and the risk of head and neck cancer: A pooled analysis in the INHANCE consortiumCancer Causes Control.201223698810.1007/s10552-011-9857-x365440122037906Search in Google Scholar
Hashim D, Sartori S, Brennan P, Curado MP, Wünsch-Filho V, Divaris K, Olshan AF, Zevallos JP, Winn DM, Franceschi S, et al. The role of oral hygiene in head and neck cancer: Results from International Head and Neck Cancer Epidemiology (INHANCE) consortium. Ann. Oncol. 2016; 27: 1619–1625.HashimDSartoriSBrennanPCuradoMPWünsch-FilhoVDivarisKOlshanAFZevallosJPWinnDMFranceschiSThe role of oral hygiene in head and neck cancer: Results from International Head and Neck Cancer Epidemiology (INHANCE) consortiumAnn. Oncol.2016271619162510.1093/annonc/mdw224495992927234641Search in Google Scholar
Marcu LG, Reid P, Bezak E. The promise of novel biomarkers for head and neck cancer from an imaging perspective. Int. J. Mol. Sci. 2018; 19: 2511.MarcuLGReidPBezakEThe promise of novel biomarkers for head and neck cancer from an imaging perspectiveInt. J. Mol. Sci.201819251110.3390/ijms19092511616511330149561Search in Google Scholar
Eze N, Lo YC, Burtness B. Biomarker driven treatment of head and neck squamous cell cancer. Cancers Head Neck. 2017; 2: 6.EzeNLoYCBurtnessBBiomarker driven treatment of head and neck squamous cell cancerCancers Head Neck.20172610.1186/s41199-017-0025-1646053131093353Search in Google Scholar
Arantes LM, De Carvalho AC, Melendez ME, Carvalho AL. Serum, plasma and saliva biomarkers for head and neck cancer. Expert Rev. Mol. Diagn. 2018; 18: 85–112.ArantesLMDe CarvalhoACMelendezMECarvalhoALSerum, plasma and saliva biomarkers for head and neck cancerExpert Rev. Mol. Diagn.2018188511210.1080/14737159.2017.140490629134827Search in Google Scholar
Dahiya K, Dhankhar R. Updated overview of current biomarkers in head and neck carcinoma. World J. Methodol. 2016; 6: 77–86.DahiyaKDhankharRUpdated overview of current biomarkers in head and neck carcinomaWorld J. Methodol.20166778610.5662/wjm.v6.i1.77480425427018324Search in Google Scholar
Arvelo F, Sojo F, Cotte C. Tumour progression and metastasis. Ecancermedicalscience, 2016; 10: 617.ArveloFSojoFCotteCTumour progression and metastasisEcancermedicalscience.20161061710.3332/ecancer.2016.617475411926913068Search in Google Scholar
Nebbioso A, Tambaro FP, Dell’Aversana C, Altucci L. Cancer epigenetics: Moving forward. PLoS. Genet. 2018; 14: e1007362.NebbiosoATambaroFPDell’AversanaCAltucciLCancer epigenetics: Moving forwardPLoS. Genet.201814e100736210.1371/journal.pgen.1007362599166629879107Search in Google Scholar
Moore LD, Le T, Fan G. DNA methylation and its basic function. Neuropsychopharmacology. 2013; 38: 23–38.MooreLDLeTFanGDNA methylation and its basic functionNeuropsychopharmacology.201338233810.1038/npp.2012.112352196422781841Search in Google Scholar
Jin B, Robertson KD. DNA methyltransferases, DNA damage repair, and cancer. Adv. Exp. Med. Biol. 2013; 754: 3–29.JinBRobertsonKDDNA methyltransferases, DNA damage repair, and cancerAdv. Exp. Med. Biol.201375432910.1007/978-1-4419-9967-2_1370727822956494Search in Google Scholar
Trimmer E: Methylenetetrahydrofolate reductase: Biochemical characterization and medical significance. Curr. Pharm. Des. 2013; 19: 2574–2593.TrimmerEMethylenetetrahydrofolate reductase: Biochemical characterization and medical significanceCurr. Pharm. Des.2013192574259310.2174/138161281131914000823116396Search in Google Scholar
Zhang H, Ma H, Li L, Zhang Z, Xu Y. Association of methylenetetra-hydrofolate dehydrogenase 1 polymorphisms with cancer: A meta-analysis. PLoS. One. 2013; 8: e69366.ZhangHMaHLiLZhangZXuYAssociation of methylenetetra-hydrofolate dehydrogenase 1 polymorphisms with cancer: A meta-analysisPLoS. One.20138e6936610.1371/journal.pone.0069366371664323894459Search in Google Scholar
Banerjee RV, Matthews RG. Cobalamin-dependent methionine synthase. FASEB J. 1990; 4: 1450–1459.BanerjeeRVMatthewsRGCobalamin-dependent methionine synthaseFASEB J.199041450145910.1096/fasebj.4.5.24075892407589Search in Google Scholar
Yamada K, Gravel RA, Toraya T, Matthews RG. Human methionine synthase reductase is a molecular chaperone for human methionine synthase. Proc. Natl. Acad. Sci. USA. 2006; 103: 9476–9481.YamadaKGravelRATorayaTMatthewsRGHuman methionine synthase reductase is a molecular chaperone for human methionine synthaseProc. Natl. Acad. Sci. USA.20061039476948110.1073/pnas.0603694103148043216769880Search in Google Scholar
Seetharam B, Li N. Transcobalamin II and its cell surface receptor. Vitam. Horm. 2000; 59: 337–366.SeetharamBLiNTranscobalamin II and its cell surface receptorVitam. Horm.20005933736610.1016/S0083-6729(00)59012-8Search in Google Scholar
Pérez-Miguelsanz J, Vallecillo N, Garrido F, Reytor E, Pérez-Sala D, Pajares MA. Betaine homocysteine S-methyltransferase emerges as a new player of the nuclear methionine cycle. Biochim. Biophys. Acta. 2017; 1864: 1165–1182.Pérez-MiguelsanzJVallecilloNGarridoFReytorEPérez-SalaDPajaresMABetaine homocysteine S-methyltransferase emerges as a new player of the nuclear methionine cycleBiochim. Biophys. Acta.201718641165118210.1016/j.bbamcr.2017.03.00428288879Search in Google Scholar
Szegedi SS, Castro CC, Koutmos M, Garrow TA. Betaine-homocysteine S-methyltransferase-2 is an S-methylmethionine-homocysteine methyltransferase. J. Biol. Chem. 2008; 283: 8939–8945.SzegediSSCastroCCKoutmosMGarrowTABetaine-homocysteine S-methyltransferase-2 is an S-methylmethionine-homocysteine methyltransferaseJ. Biol. Chem.20082838939894510.1074/jbc.M710449200227637418230605Search in Google Scholar
Jhee KH, Kruger WD. The role of cystathionine β-synthase in homocysteine metabolism. Antioxid. Redox. Signal. 2005; 7: 813–822.JheeKHKrugerWDThe role of cystathionine β-synthase in homocysteine metabolismAntioxid. Redox. Signal.2005781382210.1089/ars.2005.7.81315890029Search in Google Scholar
Quadros EV, Sequeira JM. Cellular uptake of cobalamin: Transcobalamin and the TCblR/CD320 receptor. Biochimie. 2013; 95: 1008–1018.QuadrosEVSequeiraJMCellular uptake of cobalamin: Transcobalamin and the TCblR/CD320 receptorBiochimie.2013951008101810.1016/j.biochi.2013.02.004390248023415653Search in Google Scholar
Allen LH. Vitamin B-12. Adv.. Nutr. 2012; 3: 54–55.AllenLHVitamin B-12Adv.. Nutr.20123545510.3945/an.111.001370326261422332101Search in Google Scholar
Brunaud L, Alberto JM, Ayav A, Gérard P, Namour F, Antunes L, Braun M, Bronowicki JP, Bresler L, Guéant JL. Vitamin B12 is a strong determinant of low methionine synthase activity and DNA hypomethylation in gastrectomized rats. Digestion. 2003; 68: 133–140.BrunaudLAlbertoJMAyavAGérardPNamourFAntunesLBraunMBronowickiJPBreslerLGuéantJLVitamin B12 is a strong determinant of low methionine synthase activity and DNA hypomethylation in gastrectomized ratsDigestion.20036813314010.1159/00007530714646334Search in Google Scholar
Castro R, Barroso M, Rocha M, Esse R, Ramos R, Ravasco P, Rivera I, de Almeida IT. The TCN2 776C>G polymorphism correlates with vitamin B12 cellular delivery in healthy adult populations. Clin. Biochem. 2010; 43: 645–649.CastroRBarrosoMRochaMEsseRRamosRRavascoPRiveraIde AlmeidaITThe TCN2 776C>G polymorphism correlates with vitamin B12 cellular delivery in healthy adult populationsClin. Biochem.20104364564910.1016/j.clinbiochem.2010.01.01520144600Search in Google Scholar
Stanisławska-Sachadyn A, Woodside JV, Sayers CM, Yarnell JW, Young IS, Evans AE, Mitchell LE, Whitehead AS. The transcobalamin (TCN2) 776C>G polymorphism affects homocysteine concentrations among subjects with low vitamin B12 status. Eur. J. Clin. Nutr. 2010; 64: 1338–1343.Stanisławska-SachadynAWoodsideJVSayersCMYarnellJWYoungISEvansAEMitchellLEWhiteheadASThe transcobalamin (TCN2) 776C>G polymorphism affects homocysteine concentrations among subjects with low vitamin B12 statusEur. J. Clin. Nutr.2010641338134310.1038/ejcn.2010.15720808328Search in Google Scholar
Malinowska K, Morawiec-Sztandera A, Majsterek I, Kaczmarczyk D. TC2 C776G polymorphism studies in patients with oral cancer in the Polish population. Pol. J. Pathol. 2016; 67: 277–282.MalinowskaKMorawiec-SztanderaAMajsterekIKaczmarczykDTC2 C776G polymorphism studies in patients with oral cancer in the Polish populationPol. J. Pathol.20166727728210.5114/pjp.2016.6378028155977Search in Google Scholar
Cheng J, Zhu WL, Dao JJ, Li SQ, Li Y. Relationship between polymorphism of methylenetetrahydrofolate dehydrogenase and congenital heart defect. Biomed. Environ. Sci. 2005; 18: 58–64.ChengJZhuWLDaoJJLiSQLiYRelationship between polymorphism of methylenetetrahydrofolate dehydrogenase and congenital heart defectBiomed. Environ. Sci.2005185864Search in Google Scholar
Pietrzyk JJ, Bik-Multanowski M. 776C>G polymorphism of the trans-cobalamin II gene as a risk factor for spinabifida. Mol. Genet. Metab. 2003; 80: 364.PietrzykJJBik-MultanowskiM776C>G polymorphism of the trans-cobalamin II gene as a risk factor for spinabifidaMol. Genet. Metab.20038036410.1016/S1096-7192(03)00131-814680986Search in Google Scholar
Lyman GH. Counting the costs of cancer care. Lancet Oncol. 2013; 14: 1142–1143.LymanGHCounting the costs of cancer careLancet Oncol.2013141142114310.1016/S1470-2045(13)70480-724131613Search in Google Scholar
Alho OP, Teppo H, Mäntyselkä P, Kantola S. Head and neck cancer in primary care: Presenting symptoms and the effect of delayed diagnosis of cancer cases. CMAJ, 2006; 174: 779–784.AlhoOPTeppoHMäntyselkäPKantolaSHead and neck cancer in primary care: Presenting symptoms and the effect of delayed diagnosis of cancer casesCMAJ.200617477978410.1503/cmaj.050623140239416534084Search in Google Scholar
Makni L, Zidi S, Barbiroud M, Ahmed AB, Gazouani E, Mezlini A, Stayoussef M, Yacoubi-Loueslati B. Increased risks between TLR2 (-196 to -174 ins/del) and TLR3 1377C>T variants and head and neck cancers in Tunisia. Centr. Eur. J. Immunol. 2019; 44: 144–149.MakniLZidiSBarbiroudMAhmedABGazouaniEMezliniAStayoussefMYacoubi-LoueslatiBIncreased risks between TLR2 (-196 to -174 ins/del) and TLR3 1377C>T variants and head and neck cancers in TunisiaCentr. Eur. J. Immunol.20194414414910.5114/ceji.2019.87065674554931530984Search in Google Scholar
Demokan S, Dalay N. Role of DNA methylation in head and neck cancer. Clin. Epigenetics. 2011; 2: 123–150.DemokanSDalayNRole of DNA methylation in head and neck cancerClin. Epigenetics.2011212315010.1007/s13148-011-0045-3336539122704334Search in Google Scholar
Jeziorska DM, Murray RJ, De Gobbi M, Gaentzsch R, Garrick D, Ayyub H, Chen T, Li E, Telenius J, Lynch M, et al. DNA methylation of intragenic CpG islands depends on their transcriptional activity during differentiation and disease. Proc. Natl. Acad. Sci. USA. 2017; 114: E7526–E7535.JeziorskaDMMurrayRJDe GobbiMGaentzschRGarrickDAyyubHChenTLiETeleniusJLynchMDNA methylation of intragenic CpG islands depends on their transcriptional activity during differentiation and diseaseProc. Natl. Acad. Sci. USA.2017114E7526E753510.1073/pnas.1703087114559464928827334Search in Google Scholar
Hazra A, Fuchs CS, Kawasaki T, Kirkner GJ, Hunter DJ, Ogino S. Germline polymorphisms in the one-carbon metabolism pathway and DNA methylation in colorectal cancer. Cancer Causes Control. 2010; 21: 331–345.HazraAFuchsCSKawasakiTKirknerGJHunterDJOginoSGermline polymorphisms in the one-carbon metabolism pathway and DNA methylation in colorectal cancerCancer Causes Control.20102133134510.1007/s10552-009-9464-2357097819936946Search in Google Scholar
Krakowczyk Ł, Strzelczyk JK. Epigenetic modification of gene expression in colorectal carcinogenesis. Współcz Onkol. 2007; 11: 289–294.KrakowczykŁStrzelczykJKEpigenetic modification of gene expression in colorectal carcinogenesisWspółcz Onkol.200711289294Search in Google Scholar
Zara-Lopes T, Galbiatti-Dias AL, Castanhole-Nunes MM, Padovani-Júnior JA, Maniglia JV, Pavarino EC, Goloni-Bertollo EM. Polymorphisms in MTHFR, MTR, RFC1 and CβS genes involved in folate metabolism and thyroid cancer: A case-control study. Arch. Med. Sci. 2019; 15: 522–530.Zara-LopesTGalbiatti-DiasALCastanhole-NunesMMPadovani-JúniorJAManigliaJVPavarinoECGoloni-BertolloEMPolymorphisms in MTHFR, MTR, RFC1 and CβS genes involved in folate metabolism and thyroid cancer: A case-control studyArch. Med. Sci.20191552253010.5114/aoms.2018.73091642520730899306Search in Google Scholar
De Castro TB, Rodrigues-Fleming GH, Oliveira-Cucolo JG, Silva JN, Silva FP, Raposo LS, Maniglia JV, Pavarino EC, Batista Arantes LM, Galbiatti-Dias AL, et al. Gene polymorphisms involved in folate metabolism and DNA methylation with the risk of head and neck cancer. Asian Pac. J. Cancer Prev. 2020; 21: 3751–3759.De CastroTBRodrigues-FlemingGHOliveira-CucoloJGSilvaJNSilvaFPRaposoLSManigliaJVPavarinoECBatista ArantesLMGalbiatti-DiasALGene polymorphisms involved in folate metabolism and DNA methylation with the risk of head and neck cancerAsian Pac. J. Cancer Prev.2020213751375910.31557/APJCP.2020.21.12.3751804629433369477Search in Google Scholar
Cai CQ, Fang YL, Shu JB, Zhao LS, Zhang RP, Cao LR, Wang YZ, Zhi XF, Cui HL, Shi OY, Liu W. Association of neural tube defects with maternal alterations and genetic polymorphisms in one-carbon metabolic pathway. Ital. J. Pediatr. 2019; 45: 37.CaiCQFangYLShuJBZhaoLSZhangRPCaoLRWangYZZhiXFCuiHLShiOYLiuWAssociation of neural tube defects with maternal alterations and genetic polymorphisms in one-carbon metabolic pathwayItal. J. Pediatr.2019453710.1186/s13052-019-0630-1641684230867013Search in Google Scholar
Jiang J, Zhang Y, Wei L, Sun Z, Liu Z. Association between MTHFD1 G1958A polymorphism and neural tube defects susceptibility: A meta-analysis. PLoS One. 2014; 9: e101169.JiangJZhangYWeiLSunZLiuZAssociation between MTHFD1 G1958A polymorphism and neural tube defects susceptibility: A meta-analysisPLoS One.20149e10116910.1371/journal.pone.0101169407626424977710Search in Google Scholar
Parle-McDermott A, Pangilinan F, Mills JL, Signore CC, Molloy AM, Cotter A, Conley M, Cox C, Kirke PN, Scott JM, Brody LC. A polymorphism in the MTHFD1 gene increases a mother’s risk of having an unexplained second trimester pregnancy loss. Mol. Hum. Reprod. 2005; 11: 477–480.Parle-McDermottAPangilinanFMillsJLSignoreCCMolloyAMCotterAConleyMCoxCKirkePNScottJMBrodyLCA polymorphism in the MTHFD1 gene increases a mother’s risk of having an unexplained second trimester pregnancy lossMol. Hum. Reprod.20051147748010.1093/molehr/gah20416123074Search in Google Scholar
Xuan C, Li H, Zhao JX, Wang HW, Wang Y, Ning CP, Liu Z, Zhang BB, He GW, Lun LM. Association between MTHFR polymorphisms and congenital heart disease: A meta-analysis based on 9,329 cases and 15,076 controls. Sci. Rep. 2014; 4: 7311.XuanCLiHZhaoJXWangHWWangYNingCPLiuZZhangBBHeGWLunLMAssociation between MTHFR polymorphisms and congenital heart disease: A meta-analysis based on 9,329 cases and 15,076 controlsSci. Rep.20144731110.1038/srep07311425518825472587Search in Google Scholar
Kempisty B, Sikora J, Lianeri M, Szczepankiewicz A, Czerski P, Hauser J, Jagodzinski PP. MTHFD 1958G>A and MTR 2756A>G polymorphisms are associated with bipolar disorder and schizophrenia. Psychiatr. Genet. 2007; 17: 177–181.KempistyBSikoraJLianeriMSzczepankiewiczACzerskiPHauserJJagodzinskiPPMTHFD 1958G>A and MTR 2756A>G polymorphisms are associated with bipolar disorder and schizophreniaPsychiatr. Genet.20071717718110.1097/YPG.0b013e328029826f17417062Search in Google Scholar
Sutherland HG, Hermile H, Sanche R, Menon S, Lea RA, Haupt LM, Griffiths LR. Association study of MTHFD1 coding polymorphisms R134K and R653Q with migraine susceptibility. Headache. 2014; 54: 1506–1514.SutherlandHGHermileHSancheRMenonSLeaRAHauptLMGriffithsLRAssociation study of MTHFD1 coding polymorphisms R134K and R653Q with migraine susceptibilityHeadache.2014541506151410.1111/head.1242825039261Search in Google Scholar
Stevens VL, McCullough ML, Pavluck AL, Talbot JT, Feigelson HS, Thun MJ, Calle EE. Association of polymorphisms in one-carbon metabolism genes and postmenopausal breast cancer incidence. Cancer Epidemiol. Biomarkers Prev. 2007; 16: 1140–1147.StevensVLMcCulloughMLPavluckALTalbotJTFeigelsonHSThunMJCalleEEAssociation of polymorphisms in one-carbon metabolism genes and postmenopausal breast cancer incidenceCancer Epidemiol. Biomarkers Prev.2007161140114710.1158/1055-9965.EPI-06-103717548676Search in Google Scholar
Li SY, Rong M, Iacopetta B. Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in human breast cancer. Oncol. Rep. 2006; 15: 221–225.LiSYRongMIacopettaBGerm-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in human breast cancerOncol. Rep.20061522122510.3892/or.15.1.221Search in Google Scholar
Wang L, Ke Q, Chen W, Wang J, Tan Y, Zhou Y, Hua Z, Ding W, Niu J, Shen J, et al. Polymorphisms of MTHFD, plasma homocysteine levels, and risk of gastric cancer in a high-risk Chinese population. Clin. Cancer Res. 2007; 13: 2526–2532.WangLKeQChenWWangJTanYZhouYHuaZDingWNiuJShenJPolymorphisms of MTHFD, plasma homocysteine levels, and risk of gastric cancer in a high-risk Chinese populationClin. Cancer Res.2007132526253210.1158/1078-0432.CCR-06-229317438114Search in Google Scholar
Krajinovic M, Lemieux-Blanchard É, Chiasson S, Primeau M, Costea I, Moghrabi A. Role of polymorphism in MTHFR and MTHFD1 genes in the outcome of childhood acute lymphoblastic leukemia. Pharmacogenomics J. 2004; 4: 66–72.KrajinovicMLemieux-BlanchardÉChiassonSPrimeauMCosteaIMoghrabiARole of polymorphism in MTHFR and MTHFD1 genes in the outcome of childhood acute lymphoblastic leukemiaPharmacogenomics J.20044667210.1038/sj.tpj.650022414647408Search in Google Scholar
Liu G, Qi C, Xu Q, Wu B, Wang Y, Xue C. Lack of association between methylenetetrahydrofolate dehydrogenase 1 G1958A polymorphism and prostate cancer risk: A meta-analysis. Tumor Biol. 2014; 35: 2029–2033.LiuGQiCXuQWuBWangYXueCLack of association between methylenetetrahydrofolate dehydrogenase 1 G1958A polymorphism and prostate cancer risk: A meta-analysisTumor Biol.2014352029203310.1007/s13277-013-1269-y24197977Search in Google Scholar
da Silva LM, Silva JN, Galbiatti AL, Succi M, Ruiz MT, Raposo LS, Maniglia JV, Pavarino-Bertelli EC, Goloni-Bertollo EM. Head and neck carcinogenesis: Impact of MTHFD1 G1958A polymorphism. Rev. Assoc. Med. Bras. 2011; 57: 194–199.da SilvaLMSilvaJNGalbiattiALSucciMRuizMTRaposoLSManigliaJVPavarino-BertelliECGoloni-BertolloEMHead and neck carcinogenesis: Impact of MTHFD1 G1958A polymorphismRev. Assoc. Med. Bras.201157194199Search in Google Scholar
Hazra A, Wu K, Kraft P, Fuchs CS, Giovannucci EL, Hunter DJ. Twenty-four non-synonymous polymorphisms in the one-carbon metabolic pathway and risk of colorectal adenoma in the Nurses’ Health Study. Carcinogenesis. 2007; 28: 1510–1519.HazraAWuKKraftPFuchsCSGiovannucciELHunterDJTwenty-four non-synonymous polymorphisms in the one-carbon metabolic pathway and risk of colorectal adenoma in the Nurses’ Health StudyCarcinogenesis.2007281510151910.1093/carcin/bgm06217389618Search in Google Scholar
Zheng S, Wu C, Yang W, Xia X, Lin X, Jiang L, Ding R, Jiang Y. An analysis of transcobalamin II gene polymorphisms and serum levels of homocysteine, folate and vitamin B12 in Chinese patients with Crohn’s disease. Dig. Dis. 2017; 35: 463–471.ZhengSWuCYangWXiaXLinXJiangLDingRJiangYAn analysis of transcobalamin II gene polymorphisms and serum levels of homocysteine, folate and vitamin B12 in Chinese patients with Crohn’s diseaseDig. Dis.20173546347110.1159/00047184828472811Search in Google Scholar
Green R. Peripheral neuropathy risk and a transcobalamin polymorphism: Connecting the dots between excessive folate intake and disease susceptibility. Am. J. Clin. Nutr. 2016; 104: 1495–1496.GreenRPeripheral neuropathy risk and a transcobalamin polymorphism: Connecting the dots between excessive folate intake and disease susceptibilityAm. J. Clin. Nutr.20161041495149610.3945/ajcn.116.146365511873727852614Search in Google Scholar
Oussalah A, Levy J, Filhine-Trésarrieu P, Namour F, Guéant JL. Association of TCN2 rs1801198 c.776G>C polymorphism with markers of one-carbon metabolism and related diseases: A systematic review and meta-analysis of genetic association studies. Am. J. Clin. Nutr. 2017; 106: 1142–1156.OussalahALevyJFilhine-TrésarrieuPNamourFGuéantJLAssociation of TCN2 rs1801198 c.776G>C polymorphism with markers of one-carbon metabolism and related diseases: A systematic review and meta-analysis of genetic association studiesAm. J. Clin. Nutr.20171061142115610.3945/ajcn.117.156349561178328814397Search in Google Scholar